Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 153

Sort by

Sort Order Select

Journal Articles

Gastrin for the treatment of acute graft-versus-host disease of the stomach

Blood (2025) 146 (Supplement 1): 4084.

https://doi.org/10.1182/blood-2025-4084

Published: 2025

Journal Articles

Enteral supplementation with a TGF-β-enriched polymeric diet mitigates gastrointestinal acute gvhd

Sangya Chatterjee, Lena Riegler, Ina Martin, Tamina Rueckert, Marie Czech, Valentin Wenger, Francesca Biavasco, Claudia Wehr, Joerg Buescher, Alina Hartmann, Annette Schmitt-Graeff, Wolfgang Melchinger, Natalie Koehler, Christine Greil, Robert Zeiser

Blood (2025) 146 (Supplement 1): 4081.

https://doi.org/10.1182/blood-2025-4081

Published: 2025

Journal Articles

Impact of NRAS and/or KRAS mutations on post-transplant outcomes in Acute Myeloid Leukemia: A study on behalf of EBMT-ALWP

Blood (2025) 146 (Supplement 1): 6395.

https://doi.org/10.1182/blood-2025-6395

Published: 2025

Journal Articles

Menin-inhibition boosts CAR-T cell therapy against NPM1 mutated and KMT2A-rearranged acute myeloid leukemia

Blood (2025) 146 (Supplement 1): 866.

https://doi.org/10.1182/blood-2025-866

Published: 2025

Journal Articles

NLRP6 regulates ZAP-70-erk signaling in both murine and human T cells and influences acute graft-versus-host disease(GVHD)

Blood (2025) 146 (Supplement 1): 4090.

https://doi.org/10.1182/blood-2025-4090

Published: 2025

Journal Articles

Axatilimab in combination with ruxolitinib in patients with newly diagnosed chronic graft-versus-host disease: Interim safety analysis of a phase 2, randomized study

Robert Zeiser, Annie Im, Albert Assad, Maureen Bleam, Hongfei Li, Amandeep Salhotra

Blood (2025) 146 (Supplement 1): 6012.

https://doi.org/10.1182/blood-2025-6012

Published: 2025

Journal Articles

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Blood (2025) 146 (Supplement 1): 2523.

https://doi.org/10.1182/blood-2025-2523

Published: 2025

Journal Articles

Post allo-HCT menin-inhibition enhances graft-versus-leukemia effects by endogenous retrovirus induction in AML and T-cell activation

Blood (2025) 146 (Supplement 1): 5862.

https://doi.org/10.1182/blood-2025-5862

Published: 2025

Journal Articles

Anti-inflammatory drug pegtarazimod (RLS-0071) demonstrates clinical improvement in lower gastrointestinal acute graft-versus-host disease (aGvHD) and target engagement of key inflammatory marker myeloperoxidase (MPO)

Robert Zeiser, Hannah Choe, José Antonio Pérez-Simón, Kenji Cunnion, Monzr M. Al Malki

Blood (2025) 146 (Supplement 1): 2462.

https://doi.org/10.1182/blood-2025-2462

Published: 2025

Journal Articles

Autologous, allogeneic haemopoietic stem cell transplantation and CART cell therapy for tranformed Waldenström's macroglobulinemia to high grade non-Hodgkin lymphoma. real world outcomes report from the lymphoma working party of the european society for blood and marrow transplantation (LWP EBMT)

Charalampia Kyriakou, Maud NGOYA, Nour Moukalled, Irma Khvedelidze, Silvia Montoto, Luca Castagna, Didier Blaise, Lauris Gastaud, Robert Zeiser, Marek Trneny, Malte Von Bonin, Herve Ghesquieres, Koen Debackere, Matthias Stelljes, Olivier Tournilhac, Ali Bazarbachi

Blood (2025) 146 (Supplement 1): 3718.

https://doi.org/10.1182/blood-2025-3718

Published: 2025

Journal Articles

Relapse with post-transplant tyrosine kinase inhibitor (TKI) maintenance therapy in phliladelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) after allogeneic hematopoietic stem cell transplantation: Incidence and risk factor analysis

Eshrak Al-Shaibani, Jonas Mattsson, Yu Cai, Xianmin Song, Mohsen Al Zahrani, Mohamed Elemary, Hanan Alkhaldi, Muhned Alhumaid, Ayman Saad, Francesca Biavasco, Robert Zeiser, Dennis Kim

Blood (2025) 146 (Supplement 1): 4273.

https://doi.org/10.1182/blood-2025-4273

Published: 2025

Journal Articles

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Blood (2025) 146 (Supplement 1): 4284.

https://doi.org/10.1182/blood-2025-4284

Published: 2025

Journal Articles

Unleashing intrinsic inflammation in AML using therapeutic cytokines overcomes pro-survival pathways and induces deep and durable remission In Vivo.

Blood (2025) 146 (Supplement 1): 3280.

https://doi.org/10.1182/blood-2025-3280

Published: 2025

Journal Articles

Long-term outcomes of syngeneic transplantation in multiple myeloma: Valuable legacy or obsolete option? a study from the chronic malignancies working party of the EBMT

Blood (2025) 146 (Supplement 1): 6357.

https://doi.org/10.1182/blood-2025-6357

Published: 2025

Journal Articles

Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

Blood blood.2025029712.

https://doi.org/10.1182/blood.2025029712

Published: 2025

Includes: Supplemental data

Journal Articles

FDA-approved therapies for chronic GVHD

Stephanie J. Lee, Robert Zeiser

Blood (2025) 145 (8): 795–800.

https://doi.org/10.1182/blood.2024026633

Published: 2025

Journal Articles

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Blood (2024) 144 (Supplement 1): 7418.

https://doi.org/10.1182/blood-2024-206153

Published: 2024

Journal Articles

Changes in the Mutational Landscape in Acute Myeloid Leukemia Relapse Under Allogeneic Immune Pressure

Kristina Maas-Bauer, Mehtap Yücel, Miguel Waterhouse, Dietmar Pfeifer, Ralph Wäsch, Claudia Wehr, Jürgen Finke, Robert Zeiser

Blood (2024) 144 (Supplement 1): 7416.

https://doi.org/10.1182/blood-2024-205088

Published: 2024

Journal Articles

Comparative Safety and Efficacy of Posttransplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Cardiovascular Comorbidity Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in First Complete Remission from Unrelated Donors: A Retrospective Pair-Match Analysis of EBMT ALWP

Jan Vydra, Allain-Thibeault Ferhat, Nicolaus Kröger, Tobias Gedde-Dahl, Matthias Eder, Thomas Schroeder, Urpu Salmenniemi, Gerard Socie, Jakob Passweg, Sr., Ibrahim Yakoub-Agha, Alessandro Rambaldi, Robert Zeiser, Matthias Stelljes, Kristina Carlson, Cristina Castilla-Llorente, Alexandros Spyridonidis, Fabio Ciceri, Mohamad Mohty

Blood (2024) 144 (Supplement 1): 2161.

https://doi.org/10.1182/blood-2024-198999

Published: 2024

Journal Articles

STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment

Blood (2024) 144 (Supplement 1): 4119.

https://doi.org/10.1182/blood-2024-207654

Published: 2024

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Gastrin for the treatment of acute graft-versus-host disease of the stomach

Enteral supplementation with a TGF-β-enriched polymeric diet mitigates gastrointestinal acute gvhd

Impact of NRAS and/or KRAS mutations on post-transplant outcomes in Acute Myeloid Leukemia: A study on behalf of EBMT-ALWP

Menin-inhibition boosts CAR-T cell therapy against NPM1 mutated and KMT2A-rearranged acute myeloid leukemia

NLRP6 regulates ZAP-70-erk signaling in both murine and human T cells and influences acute graft-versus-host disease(GVHD)

Axatilimab in combination with ruxolitinib in patients with newly diagnosed chronic graft-versus-host disease: Interim safety analysis of a phase 2, randomized study

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Post allo-HCT menin-inhibition enhances graft-versus-leukemia effects by endogenous retrovirus induction in AML and T-cell activation

Anti-inflammatory drug pegtarazimod (RLS-0071) demonstrates clinical improvement in lower gastrointestinal acute graft-versus-host disease (aGvHD) and target engagement of key inflammatory marker myeloperoxidase (MPO)

Autologous, allogeneic haemopoietic stem cell transplantation and CART cell therapy for tranformed Waldenström's macroglobulinemia to high grade non-Hodgkin lymphoma. real world outcomes report from the lymphoma working party of the european society for blood and marrow transplantation (LWP EBMT)

Relapse with post-transplant tyrosine kinase inhibitor (TKI) maintenance therapy in phliladelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) after allogeneic hematopoietic stem cell transplantation: Incidence and risk factor analysis

Risk factor analysis of relapse risk during FLT3-inhibitor post-transplant maintenance therapy following allogeneic hematopoietic stem cell transplantation in Acute Myeloid Leukemia with FLT3-ITD

Unleashing intrinsic inflammation in AML using therapeutic cytokines overcomes pro-survival pathways and induces deep and durable remission In Vivo.

Long-term outcomes of syngeneic transplantation in multiple myeloma: Valuable legacy or obsolete option? a study from the chronic malignancies working party of the EBMT

Menin inhibition enhances graft-versus-leukemia effects by T-cell activation and endogenous retrovirus induction in AML

FDA-approved therapies for chronic GVHD

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Changes in the Mutational Landscape in Acute Myeloid Leukemia Relapse Under Allogeneic Immune Pressure

STAT5-Activating Oncogenes Drive Oncostatin M Production Causing T Cell Exhaustion and Suppressive Myeloid Cell Recruitment

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only